CT-sensitized nanoprobe for effective early diagnosis and treatment of pulmonary fibrosis

Abstract Early diagnosis is critical for providing a timely window for effective therapy in pulmonary fibrosis (PF); however, achieving this remains a significant challenge. The distinct honeycombing patterns observed in computed tomography (CT) for the primary diagnosis of PF are typically only vis...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiwei Hou, Qijian Ji, Tianyu Tang, Yonger Xue, Lin Gao, Li Dai, Jinbing Xie
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-025-03128-0
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571332499341312
author Jiwei Hou
Qijian Ji
Tianyu Tang
Yonger Xue
Lin Gao
Li Dai
Jinbing Xie
author_facet Jiwei Hou
Qijian Ji
Tianyu Tang
Yonger Xue
Lin Gao
Li Dai
Jinbing Xie
author_sort Jiwei Hou
collection DOAJ
description Abstract Early diagnosis is critical for providing a timely window for effective therapy in pulmonary fibrosis (PF); however, achieving this remains a significant challenge. The distinct honeycombing patterns observed in computed tomography (CT) for the primary diagnosis of PF are typically only visible in patients with moderate to severe disease, often leading to missed opportunities for early intervention. In this study, we developed a nanoprobe designed to accumulate at fibroblastic foci and loaded with the CT sensitizer iodide to enable effective early diagnosis of PF. An antibody fragment (Fab′) targeting the platelet-derived growth factor receptor-α, which specifically binds to (myo)fibroblasts, was conjugated to the nanoprobe surface to enhance targeting of fibroblastic foci. Additionally, collagenase was employed to facilitate nanoprobe penetration by degrading the local collagen fibers within these foci. This approach led to significant accumulation of the CT sensitizer iodide in fibrotic lung tissues, resulting in enhanced CT imaging for the detection of fibroblastic foci and enabling early diagnosis of PF. Moreover, a dual-drug combination of oltipraz and rosiglitazone was co-loaded into the nanoparticles for the treatment of early-diagnosed PF. Remarkable therapeutic efficacy was observed in model mice with early PF using these nanoparticles. Our findings present a promising strategy for the early diagnosis of PF, potentially offering a valuable time window for effective treatment of this life-threatening disease.
format Article
id doaj-art-cabc9e0e7b9a4e6f856e8859cdb90cd9
institution Kabale University
issn 1477-3155
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series Journal of Nanobiotechnology
spelling doaj-art-cabc9e0e7b9a4e6f856e8859cdb90cd92025-02-02T12:40:57ZengBMCJournal of Nanobiotechnology1477-31552025-01-0123111910.1186/s12951-025-03128-0CT-sensitized nanoprobe for effective early diagnosis and treatment of pulmonary fibrosisJiwei Hou0Qijian Ji1Tianyu Tang2Yonger Xue3Lin Gao4Li Dai5Jinbing Xie6School of Medicine, Nanjing University of Chinese MedicineDepartment of Critical Care Medicine, Xuyi People’s HospitalNurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology; Basic Medicine Research and Innovation Center of Ministry of Education, Medical School of Southeast UniversityCenter for BioDelivery Sciences, School of Pharmacy, Shanghai Jiao Tong UniversityNurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology; Basic Medicine Research and Innovation Center of Ministry of Education, Medical School of Southeast UniversityDepartment of cariol & endodont, Nanjing Stomatological Hospital, Medical School of Nanjing UniversityNurturing Center of Jiangsu Province for State Laboratory of AI Imaging & Interventional Radiology; Basic Medicine Research and Innovation Center of Ministry of Education, Medical School of Southeast UniversityAbstract Early diagnosis is critical for providing a timely window for effective therapy in pulmonary fibrosis (PF); however, achieving this remains a significant challenge. The distinct honeycombing patterns observed in computed tomography (CT) for the primary diagnosis of PF are typically only visible in patients with moderate to severe disease, often leading to missed opportunities for early intervention. In this study, we developed a nanoprobe designed to accumulate at fibroblastic foci and loaded with the CT sensitizer iodide to enable effective early diagnosis of PF. An antibody fragment (Fab′) targeting the platelet-derived growth factor receptor-α, which specifically binds to (myo)fibroblasts, was conjugated to the nanoprobe surface to enhance targeting of fibroblastic foci. Additionally, collagenase was employed to facilitate nanoprobe penetration by degrading the local collagen fibers within these foci. This approach led to significant accumulation of the CT sensitizer iodide in fibrotic lung tissues, resulting in enhanced CT imaging for the detection of fibroblastic foci and enabling early diagnosis of PF. Moreover, a dual-drug combination of oltipraz and rosiglitazone was co-loaded into the nanoparticles for the treatment of early-diagnosed PF. Remarkable therapeutic efficacy was observed in model mice with early PF using these nanoparticles. Our findings present a promising strategy for the early diagnosis of PF, potentially offering a valuable time window for effective treatment of this life-threatening disease.https://doi.org/10.1186/s12951-025-03128-0Pulmonary fibrosisEarly diagnosisTherapeutic window timeNanoprobes
spellingShingle Jiwei Hou
Qijian Ji
Tianyu Tang
Yonger Xue
Lin Gao
Li Dai
Jinbing Xie
CT-sensitized nanoprobe for effective early diagnosis and treatment of pulmonary fibrosis
Journal of Nanobiotechnology
Pulmonary fibrosis
Early diagnosis
Therapeutic window time
Nanoprobes
title CT-sensitized nanoprobe for effective early diagnosis and treatment of pulmonary fibrosis
title_full CT-sensitized nanoprobe for effective early diagnosis and treatment of pulmonary fibrosis
title_fullStr CT-sensitized nanoprobe for effective early diagnosis and treatment of pulmonary fibrosis
title_full_unstemmed CT-sensitized nanoprobe for effective early diagnosis and treatment of pulmonary fibrosis
title_short CT-sensitized nanoprobe for effective early diagnosis and treatment of pulmonary fibrosis
title_sort ct sensitized nanoprobe for effective early diagnosis and treatment of pulmonary fibrosis
topic Pulmonary fibrosis
Early diagnosis
Therapeutic window time
Nanoprobes
url https://doi.org/10.1186/s12951-025-03128-0
work_keys_str_mv AT jiweihou ctsensitizednanoprobeforeffectiveearlydiagnosisandtreatmentofpulmonaryfibrosis
AT qijianji ctsensitizednanoprobeforeffectiveearlydiagnosisandtreatmentofpulmonaryfibrosis
AT tianyutang ctsensitizednanoprobeforeffectiveearlydiagnosisandtreatmentofpulmonaryfibrosis
AT yongerxue ctsensitizednanoprobeforeffectiveearlydiagnosisandtreatmentofpulmonaryfibrosis
AT lingao ctsensitizednanoprobeforeffectiveearlydiagnosisandtreatmentofpulmonaryfibrosis
AT lidai ctsensitizednanoprobeforeffectiveearlydiagnosisandtreatmentofpulmonaryfibrosis
AT jinbingxie ctsensitizednanoprobeforeffectiveearlydiagnosisandtreatmentofpulmonaryfibrosis